SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is experiencing a surge as news circulates about a significant government initiative to buy $200 billion in mortgage bonds, aiming to drive down interest rates. The community is buzzing with expectations of a major rally and potential short squeeze, anticipating increased housing transaction volume due to improved affordability. While some express caution about profit-taking, the overwhelming sentiment points to a renewed bullish outlook for the real estate sector.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is a prominent trending stock, driven by widespread community discussion around its potential prime contractor role in a significant drone-based border security project for Israel, which is being viewed as a major validation of its autonomous defense systems. This news, though unconfirmed by the company, has ignited strong bullish sentiment and speculation about a substantial growth "super cycle" within the broader drone and defense technology sector.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following highly positive FDA feedback, confirming no additional clinical trials are needed for its lead HS therapy, sonelokimab, paving a clear path to regulatory submission. This significant de-risking event has ignited strong community discussion, fueling speculation of an imminent Merck buyout at a substantially higher valuation and expectations of a potential short squeeze as the market fully re-evaluates the stock's intrinsic value.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is actively trending amid intense political discourse following a controversial incident involving federal agents, with the community sharply divided over the justification and legality of the use of force. This event is prompting broader conversations around law enforcement authority and civil liberties, while simultaneously drawing attention to recent policy proposals from the former president regarding housing affordability and mortgage bonds, and reigniting discussions about the Epstein files.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is actively discussed amidst political negotiations concerning the extension of Affordable Care Act (ACA) subsidies, with a recent House vote favoring a multi-year extension driving investor attention. The community is sharply divided; optimists foresee a potential short squeeze and significant upside if a bipartisan agreement is reached in the Senate, while others caution about declines if a favorable outcome doesn't materialize. This ongoing debate, coupled with recent analyst attention, places OSCR at the forefront of healthcare sector conversations.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending as investors weigh news of China's scrutiny of a recent AI acquisition against strong demand for its Ray-Ban smart glasses, which has led to a delayed international launch. The community is sharply divided, with many expressing frustration over recent stock performance and questioning the company's substantial AI investments, while others see value in its core advertising business and long-term AI potential ahead of upcoming earnings season.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is a major trending topic as discussions heat up around the potential for regulatory clarity, with mainstream media highlighting it as a notable crypto. This comes amid community buzz around rumored big tech partnerships and strong debate between long-term holders anticipating institutional adoption and those frustrated by continued price volatility.

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Inmode Ltd

InMode is a hot topic following a mixed earnings report, where better-than-expected Q3 results and an FDA clearance for Morpheus8 are overshadowed by lowered full-year guidance. Investors are deeply split: many see a heavily undervalued company with a strong balance sheet poised for a rebound, while others point to management's perceived missteps and a challenging aesthetic market as reasons for continued skepticism.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending due to significant U.S. and U.K. defense contracts, solidifying its position as an end-to-end national security space partner. The community is buzzing with anticipation for the Neutron rocket's debut and strong institutional interest, while some investors debate the current valuation and recent insider share transactions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $361,500.30 in Stock

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) major shareholder Opaleye Management Inc. bought 8,638 shares of the business's stock in a transaction on Monday, December 29th. The stock...

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Buys $944,649.03 in Stock

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) major shareholder Opaleye Management Inc. purchased 22,497 shares of Sol-Gel Technologies stock in a transaction that occurred on Wednesday...

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Opaleye Management Inc. Purchases 35,169 Shares of Stock

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) major shareholder Opaleye Management Inc. purchased 35,169 shares of the business's stock in a transaction that occurred on Tuesday, December...

Opaleye Management Inc. Purchases 1,019 Shares of Sol-Gel Technologies (NASDAQ:SLGL) Stock

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) major shareholder Opaleye Management Inc. acquired 1,019 shares of the stock in a transaction dated Monday, December 22nd. The shares were...

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $10,831.60 in Stock

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) major shareholder Opaleye Management Inc. bought 260 shares of the business's stock in a transaction that occurred on Tuesday, December 23rd...

Insider Buying: Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Buys 1,019 Shares of Stock

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) major shareholder Opaleye Management Inc. bought 1,019 shares of the firm's stock in a transaction dated Monday, December 22nd. The shares...

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases $67,771.68 in Stock

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) major shareholder Opaleye Management Inc. bought 1,626 shares of the business's stock in a transaction on Friday, December 26th. The stock...

What is HC Wainwright's Estimate for SLGL FY2025 Earnings?

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Free Report) - Equities research analysts at HC Wainwright dropped their FY2025 earnings per share estimates for shares of Sol-Gel Technologies in a research...

Sol-Gel Technologies (NASDAQ:SLGL) Receives "Buy" Rating from HC Wainwright

HC Wainwright restated a "buy" rating and issued a $50.00 price target on shares of Sol-Gel Technologies in a research note on Monday...

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Opaleye Management Inc. Buys 2,735 Shares

Sol-Gel Technologies Ltd. (NASDAQ:SLGL - Get Free Report) major shareholder Opaleye Management Inc. purchased 2,735 shares of the firm's stock in a transaction that occurred on Wednesday, December...

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Sol-Gel Technologies Ltd

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

SLGL
Sol-Gel Technologies Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SLGL News

SLGLSol-Gel Technologies Ltd